Antiemetic Use During Pregnancy

Project Title Antiemetic Use During Pregnancy
Date Posted
Monday, June 24, 2019
Project ID
to07_add_preg_ahr_wp008
Status
Complete
Deliverables
Related Links
Description

This report contains the prevalence of antiemetic use among women of reproductive age who delivered a liveborn infant in the Mini-Sentinel Distributed Database (MSDD). Results for antiemetic use are also presented for a matched comparator cohort with no live-birth deliveries during the request period.

Data from January 1, 2001 to December 31, 2014 from 15 Data Partners contributing to the MSDD were included in this report. This request was distributed to Data Partners on November 10, 2015.

Medical Product
doxylamine
granisetron
metoclopramide HCL
netupitant/palonosetron HCl
ondansetron
palonosetron
prochlorperazine
promethazine HCl
succinate/pyridoxine HCl
Health Outcome
exposure in pregnancy
Population / Cohort
Females 0 to 54 years of age
Time Period
January 1, 2001 to December 31, 2014
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER